All the latest news on the marijuana space delivered directly to your inbox.
TheSeedInvestor
Biosynthesis: Unlocking the Medical Potential of Cannabis
View the infographic on how Biosynthesis could unlock the full medical potential of Cannabis, unlocking massive market potential. 

 
13x13x1 READ MORE
Read the Investors Guide To Newly Emerging Marijuana Markets 
LEARN MORE
600x300
Canadian cannabis companies get $2 Billion Investment, 2 times more than the entire global legalized cannabis industry

Canadian cannabis companies are on a fundraising spree. New York-based Viridian Capital Advisors has reported, that Canadian cannabis industry has got $2b as investment following the announcement of legalization processes.

13x13x1 READ MORE
600x300
WHO Report Finds No Public Health Risks Or Abuse Potential For CBD - From Forbes

A World Health Organization (WHO) report has found no adverse health outcomes but rather several medical applications for cannabidiol, a.k.a. CBD, despite U.S. federal policy on this cannabinoid chemical.

13x13x1 READ MORE
600x300
This Hot Biotech Blasts Off On Patent Breakthroughs
13x13x1 READ MORE
600x300
Harvest One Closes $20,125,000 Public Financing of Debentures

Harvest One Cannabis Inc. (TSXV:HVST) is pleased to announce that it has closed its previously announced "bought deal" offering of unsecured convertible debenture units of the Company in an aggregate principal amount of $20,125,000.

13x13x1 READ MORE
Please see full disclaimers on the TheSeedInvestor.com website applicable to all content provided by TSI, wherever published or re-published: http://theseedinvestor.com/about/disclaimerDisclaimer.

This news release/advertorial is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in small-cap and micro-cap securities is highly speculative and carries an extremely high degree of risk. This website makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Compensation: A thirty-six-thousand-dollar investor relations budget is being managed by The Seed Investor. Any funds leftover after expenses for research, overhead, advertising and public relations related to InMed Pharmaceuticals Inc. (ticker symbol (CSE: IN; OTCQB: IMLFF) will be considered profit. The Seed Investor and/or entities related to The Seed Investor hold shares in (CSE: IN; OTCQB: IMLFF) and intend to sell those shares. Please review all investment decisions with a licensed inv­estment advisor. 
 
32x32x1   32x32x2   32x32x3
TheSeedInvestor.com
9375 E Shea Blvd Ste 100
Scottsdale 85260
info@theseedinvestor.com
 
©2018, All Rights Reserved  |  Unsubscribe   |   View this in Browser

To keep receiving emails from us, please add us to your address book.